tiprankstipranks
Trending News
More News >
Pharma Mar SA (PHMMF)
:PHMMF
US Market

Pharma Mar SA (PHMMF) Financial Statements

Compare
51 Followers

Pharma Mar SA Financial Overview

Pharma Mar SA's market cap is currently $1.51B. The company's EPS TTM is $-0.254106675; its P/E ratio is 66.53; and it has a dividend yield of 0.86%. Pharma Mar SA is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 174.85M€ 158.15M€ 196.34M€ 229.83M€ 269.96M
Gross Profit€ 166.67M€ 148.54M€ 182.70M€ 213.39M€ 256.24M
Operating Income€ 6.47M€ -3.83M€ 44.07M€ 92.45M€ 155.94M
EBITDA€ 21.23M€ 4.55M€ 52.07M€ 104.08M€ 155.94M
Net Income€ 26.13M€ 1.14M€ 49.36M€ 92.86M€ 137.26M
Balance Sheet
Cash & Short-Term Investments€ 154.53M€ 162.56M€ 182.42M€ 201.88M€ 195.52M
Total Assets€ 349.64M€ 340.52M€ 393.26M€ 368.39M€ 330.26M
Total Debt€ 51.08M€ 43.67M€ 42.63M€ 49.33M€ 56.66M
Net Debt€ -12.16M€ -16.36M€ -107.18M€ -64.02M€ -39.55M
Total Liabilities€ 141.28M€ 147.08M€ 170.30M€ 190.47M€ 227.54M
Stockholders' Equity€ 208.36M€ 193.44M€ 222.96M€ 177.92M€ 102.72M
Cash Flow
Free Cash Flow€ -9.48M€ -29.40M€ 29.47M€ 17.87M€ 275.94M
Operating Cash Flow€ 6.03M€ -13.45M€ 38.32M€ 25.68M€ 278.94M
Investing Cash Flow€ 1.03M€ -43.05M€ 10.88M€ 18.47M€ -119.01M
Financing Cash Flow€ -5.35M€ -32.14M€ -13.37M€ -27.41M€ -73.82M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

Pharma Mar SA Debt to Assets

Pharma Mar SA Cash Flow

Pharma Mar SA Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis